Source disclosure: February 26, 2026, 18:30 JST
SANYEI CORPORATION [8119.T]
TOKYO, Feb 26 (Pulse News Wire) – Sanyei Corporation (8119.T) announced that its board of directors decided on February 26 to sell, dissolve, and liquidate its subsidiary Benexy Co., Ltd., resulting in a special loss of ¥18 million for the fiscal year ending March 31, 2026. The decision was made based on the company's mid-term strategy 'Sanyei 2025' aimed at restructuring group operations and portfolio optimization.
Benexy’s footwear sales business, particularly the Orthofeet brand, will be transferred to newly established Orthofeet Japan Co., Ltd. The move is expected to enhance corporate value. Additionally, Sanyei will abandon claims against Benexy, leading to a special loss of ¥22 million recorded individually but offset in consolidated results.
The sale and dissolution process is scheduled to conclude by July 2026. The transaction is anticipated to impact the company's consolidated earnings negatively by approximately ¥24 million due to the sale and ¥25 million due to the dissolution, totaling a special loss of ¥49 million for the fiscal year ending March 31, 2026. These figures have already been incorporated into revised forecasts released separately today.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing